LOG IN
SIGN UP
MARKET

AXSM

AXSM

Axsome
NASDAQ

Real-time Quotes | Nasdaq Last Sale

30.18
+1.58
+5.52%
After Hours: 30.00 -0.18 -0.60% 19:24 01/18 EST
OPEN
28.30
PREV CLOSE
28.60
HIGH
30.73
LOW
28.27
VOLUME
1.44M
TURNOVER
--
52 WEEK HIGH
78.35
52 WEEK LOW
19.38
MARKET CAP
1.14B
P/E (TTM)
-9.0170
1D
5D
1M
3M
1Y
5Y
First Midwest Bank Trust Division Buys Axsome Therapeutics Inc, PROSHARES TRUST, iShares ...
Joliet, IL, based Investment company First Midwest Bank Trust Division (Current Portfolio) buys Axsome Therapeutics Inc, PROSHARES TRUST, iShares Russell Mid-Cap ETF, ISHARES TRUST, Aurinia Pharmaceuticals Inc, sells Iovance Biotherapeutics Inc, Consumer D...
GuruFocus.com · 6h ago
BRIEF-Axsome Therapeutics Provided A Response To FDA Addressing 2 Deficiencies Related To NDA For AXS-05
reuters.com · 16h ago
Down 19% in 4 Weeks, Here's Why Axsome (AXSM) Looks Ripe for a Turnaround
Axsome (AXSM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks · 1d ago
Axsome extends losses as Truist cuts target on lack of clarity for depression candidate
Axsome Therapeutics (AXSM -5.2%) is trading lower for the fourth straight session after Truist Securities slashed the price target for the biopharma company citing insufficient details on the FDA review
Seekingalpha · 4d ago
Implied Volatility Surging for Axsome Therapeutics (AXSM) Stock Options
Investors need to pay close attention to Axsome Therapeutics (AXSM) stock based on the movements in the options market lately.
Zacks · 01/07 13:32
Invesco Main Street Small Cap Fund Buys Chesapeake Energy Corp, Paycor HCM Inc, Acadia ...
Investment company Invesco Main Street Small Cap Fund (Current Portfolio) buys Chesapeake Energy Corp, Paycor HCM Inc, Acadia Healthcare Co Inc, NOV Inc, Spirit Airlines Inc, sells Signature Bank, Foot Locker Inc, Berkeley Lights Inc, AutoNation Inc, BellR...
GuruFocus.com · 12/16/2021 21:38
Royce Capital Fund Buys Thryv Holdings Inc, Barnes & Noble Education Inc, Fossil Group Inc, ...
Investment company Royce Capital Fund (Current Portfolio) buys Thryv Holdings Inc, Barnes & Noble Education Inc, Fossil Group Inc, Imax Corp, Trident Acquisitions Corp, sells , , County Bancorp Inc, , Aspen Aerogels Inc during the 3-months ended 2021Q3, ac...
GuruFocus.com · 12/15/2021 05:38
Invesco V.I. Main Street Small Cap Fund Buys Chesapeake Energy Corp, Paycor HCM Inc, Acadia ...
Investment company Invesco V.I. Main Street Small Cap Fund (Current Portfolio) buys Chesapeake Energy Corp, Paycor HCM Inc, Acadia Healthcare Co Inc, Spirit Airlines Inc, NOV Inc, sells Signature Bank, Foot Locker Inc, Berkeley Lights Inc, AutoNation Inc, ...
GuruFocus.com · 12/13/2021 21:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AXSM. Analyze the recent business situations of Axsome through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

40.00%Strong Buy
40.00%Buy
13.33%Hold
6.67%Under-perform
0.00%Sell
Analyst Price Target
The average AXSM stock price target is 81.00 with a high estimate of 180.00 and a low estimate of 26.00.
High180.00
Average81.00
Low26.00
Current 30.18
EPS
Actual
Estimate
-0.82-0.62-0.41-0.21
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 244
Institutional Holdings: 24.39M
% Owned: 64.70%
Shares Outstanding: 37.69M
TypeInstitutionsShares
Increased
64
1.91M
New
35
1.29M
Decreased
38
3.10M
Sold Out
37
2.89M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-4.74%
Pharmaceuticals & Medical Research
-1.37%
Key Executives
Chairman/President/Chief Executive Officer/Founder/Director
Herriot Tabuteau
Chief Financial Officer
Nick Pizzie
Chief Operating Officer
Mark Jacobson
Executive Vice President
Kevin Laliberte
Senior Vice President
Lori Englebert
Senior Vice President
Amanda Jones
Senior Vice President
Cedric O'Gorman
Lead Director/Independent Director
Roger Jeffs
Independent Director
Mark Coleman
Independent Director
Mark Saad
No Data
  • All
  • Financials
  • Insiders
More
About AXSM
Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders. The Company's core CNS portfolio includes five product candidates, which includes AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is an oral N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity for the treatment of major depressive disorder (MDD). AXS-07 is an oral multi-mechanistic medicine for the acute treatment of migraine. AXS-07 consists of MoSEIC (Molecular Solubility Enhanced Inclusion Complex) meloxicam and rizatriptan. AXS-09 is an oral NMDA receptor antagonist with multimodal activity consisting of esbupropion and dextromethorphan for the treatment of CNS disorders. AXS-12, reboxetine, is an oral medicine in development for the treatment of narcolepsy. AXS-14, esreboxetine is an oral medicine in development for the treatment of fibromyalgia.

Webull offers kinds of Axsome Therapeutics Inc stock information, including NASDAQ:AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.